Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimab Group ABOSTO:VIMAB 57 Equity-to-Asset is 0.02 as of Jun. 2026, which is 96% below its 10-year median of 0.51. GuruFocus rates OSTO:VIMAB with a GF Score™ of 57/100 and a GF Value™ of kr5.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,092 Business Services companies, Vimab Group AB ranks worse than 95.6% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vimab Group AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr5.0 Mil. Vimab Group AB's Total Assets for the quarter that ended in Jun. 2026 was kr221.9 Mil.
Therefore, Vimab Group AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.02.
The historical rank and industry rank for Vimab Group AB's Equity-to-Asset or its related term are showing as below:
OSTO:VIMAB'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.03 Med: 0.51 Max: 0.96
Current: 0.02
During the past 13 years, the highest Equity to Asset Ratio of Vimab Group AB was 0.96. The lowest was -0.03. And the median was 0.51.
OSTO:VIMAB's Equity-to-Asset is ranked worse than 95.6% of 1092
companies
in the Business Services industry
Industry Median: 0.52
vs OSTO:VIMAB: 0.02
Vimab Group AB (OSTO:VIMAB) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Vimab Group AB Equity-to-Asset Related Terms
Vimab Group AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Vimab Group AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:VIMAB vs VRSK, EFX, BAH: Equity-to-Asset Comparison
For the Consulting Services subindustry, Vimab Group AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimab Group AB Equity-to-Asset vs Business Services Industry
For the Business Services industry and Industrials sector, Vimab Group AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Vimab Group AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Vimab Group AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB (OSTO:VIMAB) has a Equity-to-Asset of 0.02 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Vimab Group AB and its competitors. This is 96% below median its historical median of 0.51. According to the industry distribution chart, Vimab Group AB ranks #1044 out of 1092 companies in the Business Services industry, placing it in the top 95.6%.
Is Vimab Group AB's Equity-to-Asset too high?
Vimab Group AB's current Equity-to-Asset of 0.02 is 96% below median its 10-year median of 0.51. The Business Services industry median Equity-to-Asset is 0.52. Vimab Group AB's value of 0.02 is 96.2% below this industry median. Based on the distribution chart, Vimab Group AB ranks #1044 out of 1092 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Vimab Group AB has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Equity-to-Asset compare to VRSK and EFX?
According to the Business Services industry distribution chart, Vimab Group AB ranks #1044 out of 1092 companies for Equity-to-Asset. This places Vimab Group AB in the lower half of its industry. The industry median Equity-to-Asset is 0.52. Vimab Group AB's value of 0.02 is 96.2% below this benchmark. While the company's 10-year median is 0.51 vs. the industry median of 0.52, Vimab Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Business Services company?
The median Equity-to-Asset among Business Services companies is 0.52, based on 1,092 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimab Group AB's current Equity-to-Asset of 0.02 is 96.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Vimab Group AB and its competitors. For the Business Services industry, the median Equity-to-Asset is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimab Group AB's current Equity-to-Asset is 0.02, which is 96% below median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.50, compared to a current price of kr3.85 — trading 30% below its estimated fair value. The current Equity-to-Asset is 0.02, which is 96% below median its 10-year median of 0.51 and 96.2% below the Business Services industry median of 0.52. Vimab Group AB's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Equity-to-Asset is 0.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued.
The current stock price of kr3.85 is trading 30% below its estimated GF Value™ of kr5.50.
GuruFocus considers Vimab Group AB to be Possible Value Trap.
Key valuation signals for OSTO:VIMAB:
Equity-to-Asset: 0.02 (96% below median its 10-year median of 0.51)
GF Value™: kr5.50 vs. price of kr3.85 (30% below fair value)
Industry Position: 96.2% below the Business Services median (#1044 of 1092)
No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
57GF Score
Get the complete analysis for OSTO:VIMAB
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VIMAB has been successfully added to your 
